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AObjective: The very long-term results of the double-orifice mitral valve repair are unknown. The aim of this
study was to assess the late clinical and echocardiographic outcomes of this technique in patients with degen-
erative mitral regurgitation.
Methods: From 1993 to 2000, 174 patients with severe degenerative mitral regurgitation were treated with the
double-orifice technique combined with ring annuloplasty. Mean age of patients was 52  12.8 years, New
York Heart Association class I or II was present in 71% of the patients, atrial fibrillation in 17.2%, and pre-
operative left ventricular ejection fraction was 59.5%  7.5%. Mitral regurgitation was due to anterior leaflet
prolapse in 36 patients (20.6%), bileaflet prolapse in 128 (73.5%), and posterior leaflet prolapse in 10
patients (5.7%).
Results: There were no hospital deaths. At hospital discharge, mitral regurgitation was absent or mild in 169
patients (97.1%) and moderate (2þ/4þ) in 5 patients (2.8%). Mitral stenosis requiring reoperation was detected
in 1 patient (0.6%). Clinical and echocardiographic follow-up was 97.1% complete (mean length, 11.5  2.53
years; median, 11.6 years; longest duration, 17.6 years). At 14 years, actuarial survival was 86.9%  3.37%,
freedom from cardiac death was 95.8%  1.54%, and freedom from reoperation was 89.6  2.51%. At the
last echocardiographic examination, recurrence of mitral regurgitation 3þ was documented in 23 patients
(23/169, 13.6%). Freedom from mitral regurgitation 3þat 14 years was 83.8%  3.39%. The only predictor
of recurrence of mitral regurgitation3þwas residual mitral regurgitation greater thanmild at hospital discharge
(hazard ratio, 5.7; 95% confidence interval, 1.6-20.6; P ¼ .007).
Conclusions: The double-orifice repair combined with ring annuloplasty provides very satisfactory long-term
results in patients with degenerative mitral regurgitation in the setting of bileaflet and anterior leaflet prolapse.
(J Thorac Cardiovasc Surg 2012;144:1019-26)The edge-to-edge (E-to-E) technique was introduced in the
surgical armamentarium of mitral valve repair during the
early 1990s and has been used to treat mitral regurgitation
(MR) resulting from different etiologies and mecha-
nisms.1-8 The basic concept behind the E-to-E approach is
that the competence of a regurgitant mitral valve can be
restored effectively with a functional rather than an
anatomic repair. Once the location of the regurgitant jet is
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The Journal of Thoracic and Carthe free edge of one leaflet is sutured to the corresponding
edge of the opposing leaflet exactly in correspondence to
the regurgitant jet, thereby eliminating MR. When the
approximation of the free edge of the leaflets is carried out
centrally, away from the commissural area, a double-
orifice mitral valve is created artificially. We have reported
previously the 5-year results of the double orifice repair
(DO) used for the treatment of MR resulting from different
etiologies and mechanisms.2 Effectiveness and durability
were very satisfactory, although suboptimal outcomes were
observed in patients with rheumatic valve disease and in
those who did not undergo annuloplasty. These findings
and increasing clinical experience demonstrated that the
main indication for the E-to-E technique is degenerative
MR resulting frombileaflet prolapse (BLP) or anterior leaflet
prolapse (ALP), and that a concomitant annuloplasty should
be performed concomitantly to increase the durability of the
repair. Therefore, we decided to assess the long-term (up to
17.5 years) clinical and echocardiographic outcomes of DO
mitral valve repair adopted specifically for patientswith pure
degenerative, severe MR undergoing concomitant ring
annuloplasty.diovascular Surgery c Volume 144, Number 5 1019
Abbreviations and Acronyms
ALP ¼ anterior leaflet prolapse
BLP ¼ bileaflet prolapse
DO ¼ double orifice
E-to-E ¼ edge-to-edge
IQR ¼ interquartile range
NYHA ¼ New York Heart Association
MR ¼ mitral regurgitation
PLP ¼ posterior leaflet prolapse
SAM ¼ systolic anterior motion
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Patients
All consecutive patients with severe, degenerative MR treated exclu-
sively with DO mitral repair and prosthetic ring annuloplasty at San Raf-
faele University Hospital of Milan (Italy) and at the Community Hospital
of Brescia (Italy) from 1993 to December 2000 were enrolled in this retro-
spective study. In this time frame, of the 710 patients who underwent mitral
repair for severe, degenerative MR, 268 (37.7%) received a DO repair.
Ninety-four patients were excluded according to one or more of the follow-
ing criteria: other concomitant valve replacement procedures (n ¼ 10), or
DO repair performed without annuloplasty (n ¼ 59) or with annuloplasty
techniques other than prosthetic ring implantation, including suture annu-
loplasty and partial annuloplasties with strips of pericardium or Gore-Tex
(n¼ 25). Patients with functional tricuspid insufficiency treated with an an-
nuloplasty and those with associated incidental coronary artery disease or
atrial septal defect were retained. The final study population consisted of
174 patients (174/710, 24.5%). Demographic and surgical data were ob-
tained from hospital records and reviewed. The institutional ethics commit-
tee approved this study and waived individual consent for this retrospective
analysis. Preoperative characteristics of the patients are reported in Table 1.
Mean age of the study population was 52  12.8 years, New York Heart
Association (NYHA) class I or II was present in 71% of the patients, atrial
fibrillation was present in 17.2%, and preoperative left ventricular ejection
fraction was 59.5%  7.5%. MR was the result of BLP in 128 patients
(73.5%), ALP in 36 patients (20.6%), and posterior leaflet prolapse
(PLP) in 10 patients (5.7%).Operative Technique
All operations were carried out through a conventional median sternot-
omy using normothermic cardiopulmonary bypass and cold-blood cardio-
plegia with the exception of 4 young patients (4/174, 2.2%) in whom
aminimally invasive approachwas preferred. Themitral valvewas exposed
through the left atrium with the incision made in the interatrial groove. The
surgical technique of DO mitral repair has been described previously.9,10
Briefly, the mitral valve is inspected carefully to confirm the preoperative
transesophageal echocardiographic findings. In Barlow’s disease with
bileaflet involvement, the entire valve is usually prolapsing, although the
middle scallops of the anterior and posterior leaflets (A2 and P2) are
usually the segments showing the most severe pathologic involvement. A
4-0 polypropylene stitch is passed through the mid portion of the
anterior and posterior leaflets (A2 and P2), and a DO mitral valve is
created. After checking that valve symmetry is respected and distortion
is avoided, a continuous mattress suture is performed followed by an
over-and-over continuous suture with the same 4-0 polypropylene. The
length of the suture depends on the extension of the noncoapting zone of
the facing leaflets. As a general rule, it should be as short as possible to
avoid mitral stenosis. The distance of the suture bites from the free edges
is variable, according to the redundancy of the leaflets. Typically in1020 The Journal of Thoracic and Cardiovascular SurBarlow’s disease, it is around 1 cm or more to decrease the height of the
myxomatous leaflets and to prevent postoperative systolic anterior motion
(SAM). In the presence of prolapse/flail involving only one leaflet, the pro-
lapsing/flailing segment has to be included in the E-to-E suture, the position
of which, in this circumstance, may be somewhat asymmetric, correspond-
ing to the center of the prolapsing/flailing portion of the leaflet. In this case,
the size of the two orifices may be different, one being larger than the other
one. The global mitral valve area is assessed by direct inspection and, when
in doubt, by introducing Hegar dilators into the orifices. A global valve area
of more than 2.5 cm2 is considered acceptable for normal-size patients.
Valve competence is evaluated by forceful saline injection into the left
ventricle. Last, transesophageal echo Doppler is performed routinely after
weaning from cardiopulmonary bypass to assess the competence of the
valve and to measure the valve area, usually by a planimetric method using
the transgastric short-axis view. All patients included in this series had
a concomitant annuloplasty with a semirigid or rigid prosthetic ring. The
size of the ring was chosen according to the intertrigonal distance and
the surface area of the anterior leaflet (mean size, 36.6  2.5 mm).
Twenty-six patients (26/174, 14.9%) required 1 or more concomitant
cardiac operations, as reported in Table 1.
Follow-up
Clinical and echocardiographic follow-up information was available for
169 patients (97.1% complete). Five patients were lost to follow-up. The
mean length of follow-up was 11.5  2.53 years (range, 1.1-17.6 years)
with a median of 11.6 years (interquartile range [IQR], 10.4-12.6 years).
The majority of the patients were referred to us from remote geographic
areas and, therefore, data were collected either through outpatient visit
and transthoracic echocardiography in our institution in 55 patients
(32.5%) and by telephone contact with the patient and the referring cardi-
ologist in 114 patients (67.5%). For all those 114 patients, the report of at
least 1 transthoracic echocardiogram performed by the referring local car-
diologist within the previous 6 months was available and recorded.
Statistical Analysis
Calculations were performed using SPSS version 11.5 (SPSS Inc, Chi-
cago, Ill) for Windows (Microsoft Corp, Redmond, Wash). Data are
expressed as mean  SD or as median and IQR. For continuous, normally
distributed data, comparison between 2 groups was performedwith Student
t test for (un)paired samples as indicated. If continuous data were not dis-
tributed normally, theMann-WhitneyU test orWilcoxon’s signed-rank test
were used for independent or related samples, respectively. Comparison of
categorical variables was performed using c2 and Fisher’s test. NYHA
functional class and grade of MR were treated as ordinal variables and
compared with Wilcoxon’s signed-rank test (related samples) or with the
Mann-Whitney U test (independent samples). Survival and freedom from
events were evaluated by Kaplan-Meier analysis. For actuarial estimates,
data are presented as mean  standard error. Comparison among groups
was performed according to the log-rank method. Univariate analysis of
predictors of recurrence of MR 3þwas performed with Cox proportional
hazards regression.RESULTS
Mortality and Morbidity
There were no hospital deaths. The postoperative course
was rather smooth in most patients. Early and late compli-
cations are detailed in Table 2. Eighteen patients died after
hospital discharge. The cause of death was cardiac related
in 7 patients: 2 cases of acute myocardial infarction, 1
case of pulmonary edema, 3 cases of sudden deaths, and 1
case of aortic dissection. Actuarial survival at 14 yearsgery c November 2012
TABLE 1. Baseline characteristics of the patients and operative data
No. of patients 174
Age, y 53.2  12.8
Male sex, n (%) 113 (64.9)
NYHA class, n (%)
I 48 (27.5)
II 76 (43.6)
III 50 (28.7)
Atrial fibrillation at presentation, n (%) 30 (17.2)
Mechanism of MR, n (%)
Flail/prolapse of both leaflets 128 (73.5)
Flail/prolapse of the anterior leaflet 36 (20.6)
Flail/prolapse of the posterior leaflet 10 (5.7)
Ejection fraction,% 59  7.5
Ring used for mitral annuloplasty, n (%)
Seguin St. Jude Medical 140 (80.4)
Carpentier-Edwards classic 34 (19.5)
Mean size of annuloplasty ring (mm) 36.6  2.5
Associated procedures, n (%)
ASD correction 1 (0.5)
PFO closure 3 (1.7)
CABG 3 (1.7)
Tricuspid annuloplasty 7 (4)
Radiofrequency ablation of AF 12 (6.8)
NYHA, New York Heart Association;MR, mitral regurgitation; ASD, atrial septal de-
fect; PFO, patent foramen ovale; CABG, coronary artery bypass grafting; AF, atrial
fibrillation.
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95.8%  1.54%.
Reoperation
Seventeen patients (6 with ALP and 11 with BLP) were
reoperated for significant mitral stenosis (1 patient) or se-
vere MR (16 patients) between 1 month and 14.2 years afterTABLE 2. Postoperative and late complications
Complications n (%)
Postoperative morbidity
Low-output syndrome 5 (2.8)
Prolonged ventilatory support (>48h) 4 (2.3)
Reexploration for bleeding 3 (1.7)
Pericardial effusion 3 (1.7)
Pacemaker implantation 2 (1.1)
Stroke 1 (0.5)
Transischemic attack 1 (0.5)
Sternal rewiring 1 (0.5)
Late complications
Acute myocardial infarction 2 (1.1)
Stroke 2 (1.1)
Congestive heart failure 3 (1.7)
Pacemaker implantation 9 (5.1)
Pericarditis 1 (0.5)
PTCA stenting for angina 2 (1.1)
Right ventricular failure 1 (0.5)
Aortic dissection 1 (0.5)
PTCA, Percutaneous transluminal coronary angioplasty.
The Journal of Thoracic and Carthe initial repair (mean, 6.1 4.1 years; median, 6.8 years).
Mitral stenosis requiring reoperation was detected in 1 pa-
tient (0.6%) with preoperative Barlow’s disease and BLP
who underwent mitral valve replacement about 1 month af-
ter DO repair. The atrioventricular obstruction was found to
be at the subvalvular level on transesophageal echocardiog-
raphy and was the result of the impingement of hypertro-
phic papillary muscles in the orifices of the valve. The
remaining 16 patients were all reoperated because of severe
MR. Three of them already had residual moderate (2þ/4þ)
MR at hospital discharge. Reoperations were performed
in our institution for 8 patients and in other centers in the
remaining 9 patients. The cause of recurrence of MR could
be established in 4 patients only and was recurrent leaflet
prolapse (2 patients) and anterior leaflet flail resulting
from to a new chordal rupture in correspondence to the pos-
terior orifice of the DO repair (1 patient). In the 4th patient,
recurrent MR was a result of tearing of the leaflet by the
E-to-E suture, associated with severe hemolysis secondary
to partial prosthetic ring detachment. In the remaining 12
patients, the mechanism responsible for recurrent MR re-
mained unclear either because reoperations were performed
at other institutions or because this information was not de-
scribed in detail in the operative reports. At reoperation, 16
patients had successful mitral valve replacement and 1
received a re-repair with a new E-to-E. Actuarial freedom
from reoperation at 14 years was 89.6%  2.51%
(Figure 1) and was not significantly different in BLP versus
ALP (90.6% 2.96%vs 82% 6.64% at 12 years,P¼ .22).
Echocardiographic Follow-up and Functional Status
All patients underwent transesophageal echocardio-
graphic control in the operating room followed by transtho-
racic echocardiogram at discharge. At hospital discharge,
MR was absent or mild in 169 patients (97.1%) and moder-
ate (2þ/4þ) in 5 patients (2.8%). One hundred sixty-nine
patients (169/174, 97.1%) had at least 1 transthoracic echo-
cardiogram performed at the last follow-up at a mean of
10.7 3.1 years (median, 11.2 years; IQR, 10.2-12.1 years)
after mitral repair. Mitral stenosis requiring reoperation was
detected in 1 patient (0.6%). At the last follow-up, mean
mitral valve area was 3.2  0.4 cm2 and MR was absent
in 42 patients (24.8%), mild in 83 (49.1%), moderate in
21 (12.4%), moderate to severe in 6 (3.5%), and severe
in 17 patients (10%). Recurrence of MR  3þoccurred at
a median of 8.2 years (IQR, 2.8-10.7 years) after the initial
repair. Freedom from MR  3þ at 14 years was 83.8 
3.39% (Figure 2). The mechanism ofMRwas not identified
as a risk factor for recurrentMR 3þ. In particular, freedom
from MR  3þwas not significantly different in patients
with BLP or ALP (at 12 years, 86.3%  3.54% vs 82%
 6.64%; P ¼ .54). The only predictor of recurrence of
MR  3þwas residual MR greater than mild at hospital dis-
charge (hazard ratio, 5.7; 95% confidence interval, 1.6-20.6;diovascular Surgery c Volume 144, Number 5 1021
FIGURE 1. Actuarial freedom from reoperation (the standard error of the
mean is shown as error bars). Pts, patients.
TABLE 3. Predictors of recurrence of mitral regurgitation 3þ
Predictor HR 95% CI P value
Age 1.01 0.97-1.04 .52
Male sex 2 0.74-5.43 .16
LVEF 0.97 0.86-1.09 .68
NYHA>2 0.88 0.32-2.41 .81
Atrial fibrillation 0.51 0.11-2.24 .37
Bileaflet prolapse 0.78 0.32-1.88 .58
Anterior leaflet prolapse 1.6 0.66-3.99 .28
Posterior leaflet prolapse 0.48 0.06-3.63 .47
Associate procedures 1.07 0.31-3.64 .90
MR>1þat discharge 5.78 1.61-20.6 .007
HR, Hazard ratio; CI, confidence interval; LVEF, left ventricular ejection fraction;
NYHA, New York Heart Association; MR, mitral regurgitation.
Acquired Cardiovascular Disease De Bonis et al
A
C
DP¼ .007). None of the other preoperative variables reached
statistical significance; therefore, a multivariable analysis
was not performed (Table 3). All patients with recurrent se-
vere (4þ/4þ) MRwere reoperated with the exception of 1 pa-
tient in whom severeMR developed 12 years after the initial
repair and who has refused surgery so far. Freedom from theFIGURE 2. Actuarial freedom from echocardiographic recurrence of MR
 3þ (the standard error of the mean is shown as error bars). MR, Mitral
regurgitation; Pts, patients.
1022 The Journal of Thoracic and Cardiovascular Surcombined end point of reoperation andMR 3þat 14 years
was 83.4%  3.4% (85.6% 3.58% for BLP and 82% 
6.64% for ALP, P ¼ .62). From a functional point of view,
NYHA class I was documented in 112 patients (66.2%),
NYHA class II in 49 (28.9%), and NYHA class III in 8
(4.7%; P ¼ .0001 compared with preoperative values).DISCUSSION
The main finding of this study is that the DO mitral valve
repair combined with ring annuloplasty provides satisfac-
tory long-term results in patients with degenerative MR in
the setting of BLP and ALP. The DO technique was intro-
duced by our group during the early 1990s essentially to
treat patients with severe MR resulting from prolapse of
both leaflets, prolapse of the anterior leaflet and prolapse
of the posterior leaflet in the presence of an extensively cal-
cified annulus. In addition, it was applied initially to correct
MR resulting from different etiologies, including rheumatic
disease.1,9,10 The 5-year results of the DO repair used in
such a large variety of mechanisms and etiologies were re-
ported previously by our group.2 Very satisfactory out-
comes were observed in patients with degenerative MR
undergoing DO repair combined with annuloplasty. Con-
versely, suboptimal results were demonstrated in patients
with rheumatic valve disease and in those who did not un-
dergo a concomitant annuloplasty. Therefore, about 20
years after its introduction, we decided to assess the long-
term results of this surgical approach when it is adopted
in the right setting and with the proper surgical tech-
nique—namely, in degenerative MR and with a simulta-
neous prosthetic ring annuloplasty. For this reason, we did
not include in this study population patients withMR result-
ing from etiologies other than degenerative MR as well as
those who underwent DO repair without annuloplasty (or
with annuloplasty techniques other than a prosthetic ring
implantation). Indeed, particularly at the beginning of our
experience, a ring annuloplasty was mostly avoided in pa-
tients with an extensively calcified annulus.11 Similarly,
partial annuloplasties with Gore-Tex or pericardial stripsgery c November 2012
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Dwere not standard procedures and were usually combined
with the DO technique in case of partial calcification of
the mitral annulus, which prevented the implantation of
a full prosthetic ring. Although avoiding decalcification
was attractive in this setting, we have learned that this solu-
tion is often associated with suboptimal results. Nowadays,
in these circumstances, we recommend mitral repair with
annular decalcification followed by ring annuloplasty or mi-
tral valve replacement rather than ringless E-to-E repair.
The fact that our series, as several others reported in the lit-
erature,12-14 includes only patients with concomitant ring
annuloplasty needs to be considered when we compare it
with other studies also enrolling patients treated without
annuloplasty. The absence of annuloplasty, indeed,
has been identified as an important predictor of recurrence
of MR.15,16 Most of the patients included in this study
had severe degenerative MR resulting from BLP, and
a minority of them had segmental prolapse of the anterior
leaflet. Only 10 patients underwent DO repair for isolated
PLP, and this happened at the very beginning of our
experience with the E-to-E technique, usually in patients
with poor preoperative conditions or with left ventricular
dysfunction requiring concomitant coronary artery bypass
graft, to proceed with a quick operation and have a short
aortic crossclamp time. We were curious to see the very
long-term outcomes of those few patients (which were actu-
ally very good) and retained them in the study population.
However, besides those 10 patients, all patients with PLP
have been treated in our institution with the standard qua-
drangular resection and its modifications (sliding plasty,
folding plasty, etc). This technique has been able to provide
outstanding outcomes more than 20 years after the initial re-
pair and remains the gold standard for patients with PLP at
our institution. The E-to-E approach, in this setting, has
been reserved only for a few selected patients and for those
with an extensively calcified annulus.
In the current study there was no hospital mortality. Late
mortality, to the best of our knowledge, was unrelated to the
repair technique. As in many other series of patients treated
with mitral valve reconstruction, postoperative morbidity
and late complications were low. Early after surgery, mitral
stenosis requiring reoperation occurred in only 1 patient,
and 5 more patients had a suboptimal immediate result
with moderate (2þ/4þ) residual MR at hospital discharge,
3 of whom required late reoperation for recurrent, severe
MR. From a technical point of view, it should be empha-
sized that the time frame of this study includes the very be-
ginning of our experience; therefore, the results are, at least
in part, influenced by the normal learning curve that is pres-
ent when any new technique is introduced. None of the
patients required reoperation for postoperative SAM, dem-
onstrating that, if the E-to-E suture is performed with deep
bites to decrease the height of the leaflets, a postoperative
SAM can be prevented effectively even in hugeThe Journal of Thoracic and Carmyxomatous BLP resulting from Barlow’s disease. The
long-term results of this study in terms of survival and free-
dom from cardiac death are at least comparable with those
described in other series with similar follow-up pe-
riods.12,15-20 Our result of 90% freedom from reoperation
at 14 years, in a population of patients affected mainly by
BLP and ALP, is very satisfactory and remains within the
range reported in the literature by other groups using
conventional repair techniques and with a duration of
follow-up ranging from 10 to 20 years.12,15-19,21 Freedom
from reoperation was not significantly different in patients
with BLP versus ALP. Nevertheless, patients with ALP
had freedom from reoperation and from recurrence of MR
 3þ at 12 years, which was lower than that described
previously by our group.8 Possible explanations for this
finding are that the number of patients with ALP in this
study was only 36, representing just a minority (about one
quarter) of the 133 patients included in the study published
previously, and that the median follow-up of the patients
with ALP in the current study was around 11 years com-
pared with 3 years in our previous series. One strength of
this study is that the long-term effectiveness and durability
of the DO technique was demonstrated not only by
freedom from reoperation but also by the echocardiographic
controls, which were available in 97.1% of the patients. In
the literature, long-term echocardiographic data in patients
with BLP and ALP treated with mitral repair are reported
rarely.15,17,20 Our result of 84% echocardiographic
freedom from MR  3þ at 14 years can be considered
very satisfactory and at least comparable with those
described in this setting by other advanced mitral valve
repair centers.15,17,20 The mechanism of MR had no
influence on survival, freedom from cardiac death,
freedom from reoperation, and recurrence of MR  3þ.
The only predictor of recurrence of MR  3þ was the
presence of residual MR greater than mild at hospital
discharge, confirming the importance of a perfectly
competent mitral valve at the end of the reconstructive
procedure. In the very few patients in whom the cause of
recurrence of MR could be established, it was the result of
the progression of the degenerative disease with the
occurrence of new prolapsing or flailing lesions in
correspondence to 1 of the 2 orifices of the E-to-E repair.
Tearing of the leaflet by the E-to-E suture occurred in 1
patient only, together with prosthetic ring detachment.
According to intraoperative findings, we can speculate
that a too superficial stitch of the E-to-E suture was likely
the cause of leaflet tearing. Last, about 70% of the
patients in this series underwent mitral repair for severe
MR when they were relatively asymptomatic or when they
had few symptoms (NYHA I or II). Still, an important
clinical improvement was documented at follow-up, with
more than 95% of the patients in NYHA functional class I
or class II.diovascular Surgery c Volume 144, Number 5 1023
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This study has all the limitations of every retrospective
data collection. In addition, the sample size is rather small,
particularly with regard to patients with ALP.Moreover, be-
cause 67.5% of the patients had an echocardiographic
examination performed at other institutions, we cannot ex-
clude that the rate of recurrent MR in those patients might
have been underestimated. However, this event seems rather
unlikely because of the consistency between the good echo-
cardiographic late outcomes reported and the very satisfac-
tory clinical conditions described by the patients. In
addition, no consistent data were available in terms of left
ventricular dimensions, right ventricular function, and sys-
tolic pulmonary artery pressure at follow-up, and therefore
they could not be analyzed and compared with preoperative
values. Another limitation of this study is represented by the
fact that the causes of recurrent MR remain unknown in
most patients either because they were reoperated at other
institutions or because this information could not be re-
trieved from the operative reports. Last, as we emphasized
earlier, this study includes a selected group of patients,
and this needs to be taken into account when looking at
the late outcomes of this technique. Only patients with de-
generativeMR resulting primarily fromBLP or ALP treated
with a DO repair combined with ring annuloplasty were in-
cluded. The results reported in this series, therefore, cannot
be extended to patients submitted to DO technique without
concomitant annuloplasty and to cases of MR resulting
from etiologies other than degenerative.
CONCLUSION
In conclusion, our clinical and echocardiographic data
confirm that the DO mitral valve repair, combined with
ring annuloplasty, provides very satisfactory long-term re-
sults in patients with degenerative MR in the setting of
BLP and ALP.
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Dr Donald D. Glower (Durham, NC). You have just heard De
Bonis and colleagues present what is probably one of the world’s
longest and largest series of edge-to-edge or double-orifice repairs
for mitral valve prolapse. This series is important in documenting
the results that can be achieved in selected patients using yet an-
other potentially powerful tool for mitral valve repair.
Personally, it took me several attempts to get the feel for this
technique, but over the past 6 years I found the technique to be use-
ful, even in repairing most cases of posterior leaflet prolapse, with-
out leaflet resection. I feel that the edge-to-edge repair may
minimize the potential for SAM in large myxomatous valves re-
paired without leaflet resection where even a 40-mm ring may
be too small in some of those patients, and the edge-to-edge repair
may add an additional safety factor in ensuring good long-term
leaflet coaptation, particularly in patients with complex myxoma-
tous valves. I have 3 questions for you.
Could you clarify, based on your experience to date and if we
limit ourselves to patients with prolapse only, what would yougery c November 2012
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Dsay might be potential indications and contraindications for using
the edge-to-edge or double-orifice technique?
Dr De Bonis. Sorry, I can’t really hear you. Contraindications?
Dr Glower. I think you have talked about in the past that you
would not use this in rings less than 30 mm. Is there anything
you would see about a patient that would cause you not to use
this technique?
Dr De Bonis. I would say that one contraindication is annular
calcification.We excluded those patients from this series. At the be-
ginning, we thought that the edge-to-edge technique could be a very
good solution in patients with a heavily calcified annulus—a simple
technique, a suture between the 2 leaflets that we hoped could be
long-lasting. That is not true. So one contraindication is annular cal-
cification.Wewould now decalcify the annulus and use this or other
techniques after decalcification or replace the valve.
Another contraindication is the presence, of course, of a small
annulus. If you have to put in a small ring, then the risk of stenosis
increases, but this is seen in a relatively small number of patients. If
you ask me which ring we have been using, we have been using in
the degenerative setting semirigid, complete rings from30 up to 40.
Most of the patients have got the ring 36 or 38, but there is a limited
number of patients with No. 30 rings. In those patients, the residual
mitral valve area is borderline, which means between 2 cm2and 2.5
cm2, but we had no major problems in terms of mitral stenosis.
Dr Glower. The data you have presented were patients all oper-
atedmore than 10 years ago, up to the year 2000. Have you changed
your technique since the year 2000 or your selection criteria?
Dr De Bonis. There have been some changes. In terms of rings,
for instance, we are not using anymore a complete ring. We are us-
ing almost exclusively a partial posterior band from trigone to trig-
one. I don’t think this is really going to make a major difference in
terms of long-term results. We didn’t find any difference between
the complete ring or the partial ring. So that is one modification we
did. Moreover, we have been using the edge-to-edge technique in
a less aggressive way than we were doing before. We are not using
this technique anymore in rheumatic disease, and we have been us-
ing artificial chordae or conventional reconstructions also for Bar-
low’s disease.
But still, this is a technique which is in our armamentarium and
we use it anytime we think it can be particularly useful—for in-
stance, when you need a quick operation, when you have to do
multiple procedures, in case of a particularly complex repair, or
when you have opposite lesions on facing segments of the anterior
and posterior leaflets. Those are a relatively small number of pa-
tients, but they do exist. For instance, you can have an important
prolapse of the anterior leaflet combined with hypoplasia or teth-
ering of the posterior one resulting from dilatation of the left ven-
tricle. Those types of opposing lesions can be very well addressed
by the edge-to-edge technique.
Dr Glower. You mentioned that you started out applying the
technique even to patients with posterior leaflet prolapse but
have backed off of that. Do you think there is a role for this?
Dr De Bonis. That is a very interesting question. I would like to
emphasize that this is a very early series of patients. So, of course,
there is a lot of learning curve.But as it has been reported in the slides
and in the paper, 10 patients had isolated posterior leaflet prolapse.
Nowadays wewould not use the edge-to-edge technique for isolated
prolapse of the posterior leaflet. We use conventional techniques,The Journal of Thoracic and Carfolding, sliding, whatever. The results at long term of the classical
Carpentier techniques in this setting are extremely good.
But what is interesting is that none of the patients with posterior
leaflet prolapse reported in this series have been reoperated or did
have recurrent MR. Among those patients, 1 died, not from
a valve-related cause, but the other 9 patients have a perfectly com-
petent valve.
So the question is: Does it work? I think so; I think it does work.
Do you have to use it? We don’t, but it is up to the surgeon. And I
don’t see a specific contraindication to use it.
Dr Glower. Thank you. Excellent paper.
DrWalaa A. Saber (Cairo, Egypt). Can you tell us, please, if in
all your patients the edge-to-edge repair was central? In other
words, the double orifice is always equal or sometimes you have
unequal orifices?
Dr De Bonis. Thank you very much for your question. I would
like to emphasize that this series includes just patients with double-
orifice mitral valve repair. So this series is just a series of patients
with central edge-to-edge stitch. Those with commissural edge-to-
edge have been excluded. We have reported them and published.
We have had very good results with the commissural edge-to-
edge technique. In that specific setting, which is commissural pro-
lapse, the edge-to-edge technique remains the first choice in our
hands, and the results are really very good.
When you perform a central edge-to-edge technique, you have
to keep in mind that your suture has to address the lesions, which
means that if you have the flail that is between A1 and A2, it is not
necessary to put the stitches in the central portion of A2, because
you don’t want to leave the flailing segment that is closer to A1. So
your suturemust be asymmetric; otherwise, youwill not get a com-
petent valve. So you can end up with orifices that are of different
sizes, but this doesn’t matter, because computational models have
shown that the valve is going to behave as a valve that has an area
that is the sum of the 2 orifices. So it doesn’t matter if one orifice is
2 cm2 and the other one is 1 cm2 or they are both 2 cm2.
Did I answer your question?
Dr Saber. Yes. Thank you.
Dr Robert A. Dion (Genk, Belgium). Congratulations, Mi-
chele, for a very nice presentation. I just have 2 small questions.
First, did you ever do a stress test to measure the gradient at exer-
cise? Second question: How do you decide that a ring is too small
for these particular patients?
Dr De Bonis. Thank you very much, Dr Dion. Indeed, I did not
show that for time reasons and also because that is not part of this
study, but 30 of those patients, exactly those patients, with ring and
edge-to-edge repair, were submitted to exercise echocardiography.
This paper has been published in the Journal of Heart Valve Dis-
ease in 2002, first name is Dr Agricola, and there we addressed
your question.
So we put the patients on the bicycle, we did an exercise test,
and the mean area at baseline was 3.2 cm2. During exercise it be-
came, at the peak of the exercise, 4.3 cm2. In terms of gradient, the
mean gradient at baseline was 2.8 mm Hg and it increased to 4.6
mm Hg. We never found pulmonary hypertension, so we excluded
the possibility of stenosis.
Addressing your second question, when you decide the ring is
too small, that is very important. It is really a matter of experience.
Just by looking at the 2 orifices with the forceps when you havediovascular Surgery c Volume 144, Number 5 1025
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too small. In addition, it is even easier if you just put a Hegar in-
side. So if I am putting a 30-mm ring, I start to be concerned,1026 The Journal of Thoracic and Cardiovascular Surbut, in case of doubt, I can always measure the size of the orifices.
For instance, if I can put in a Hegar which is No. 20, there is no risk
of stenosis at all.gery c November 2012
